Clinical Trial Update: Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetic study of cabazitaxel in patients with advanced solid tumors and liver impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Tumor

Drugs mentioned

• Jevtana (cabazitaxel)

Snippet

Sponsor: Sanofi | Conditions: Neoplasm Malignant | Phase 1 | Status: COMPLETED